LVGO News and Press, Livongo Health Inc. From 05/29/20

Stocks are soaring lately, and it's easy to wonder if the big gains have already been earned. There are more than 1,500 stocks that have at least doubled since bottoming out between mid-March and early April, but it wouldn't be a surprise to see many of them retreat. A lot of these near-term wi...

Shares of Livongo Health (NASDAQ: LVGO) were jumping 11.2% higher as of 3:22 p.m. EDT on Thursday. The company didn't report any news. Investors appear to be buying the healthcare stock on the dip after it declined 8% in the first two trading days of the week.  There's a good reason ...

Synopsis The COVID-19 pandemic has led to a change in lifestyles and working practices. These changes, plus the advent of 5G, are accelerating tech spending, particularly for bandwidth, data transfer speeds, for security and for many internet related services. Investors have been quick to ...

No-brainer stocks may be hard to come by in today's market. After all, the  S&P 500 has rebounded more than 36% from the low it hit on March 23 and is within breathing distance of the all-time high it set on February 19, just a little more than 10% off its peak. At the same time, the ...

When it comes to investing in small up-and-coming businesses, picking just one or two usually won't suffice. Some won't survive, others will stagnate, and even those that do eventually provide big investment returns are incredibly volatile along the way. My picks last autumn (outlined in one pie...

The following slide deck was published by Livongo Health, Inc. in conjunction with this Read more ...

For much of the past three months, Wall Street has been taken on a once-in-a-lifetime ride . Panic surrounding the spread of the coronavirus disease 2019 (COVID-19) wound up pushing the benchmark S&P 500 down as much as 34% in just over a month. Although the market fiercely bounced back i...

As an investor, you've witnessed record levels of volatility over the past three months. Although we've bounced quite a bit off of the March 23 lows, it doesn't mask the fact that uncertainties tied to the coronavirus disease 2019 (COVID-19) pandemic pushed the benchmark S&P 500 down 34% i...

Amended regulations issued by the Food & Drug Administration (FDA), including in response to the COVID-19 pandemic, are expected to turbocharge revenues for diabetes companies and leading to analyst upgrades. According to the latest 2020 statistics compiled by the Centers for Disease Cont...

For nearly three months now, Wall Street and investors have had their resolve tested like never before due to the spread of the coronavirus disease 2019 (COVID-19). Although the stock market has rebounded quite a bit off of its lows, it doesn't overshadow the record-breaking volatility we witnes...